Dartmouth-Hitchcock Medical Center: Lung Neoplasms trials

The registry lists 12 Lung Neoplasms studies with Dartmouth-Hitchcock Medical Center as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 3Phase 2 2Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Healthy Homes StudyRecruitingNCT05833334Not applicable
• Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00487669Phase 2Results posted
• Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00153803Phase 3Results posted
• Study of Tarceva and Targretin in Stage I-II Lung CancerCompletedNCT00125372Not applicableResults posted
• Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung CancerTerminatedNCT00003726Phase 1/2Results posted
• Understanding Rural Patient and Provide Preferences for Mobile Lung Cancer Screening ClinicsSuspendedNCT04926662
• A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation (REM)TerminatedNCT03500393Not applicable
• A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer SurgeryCompletedNCT03162718Not applicable
• Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort StudyCompletedNCT02575898Not applicable
• A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung CancerWithdrawnNCT01611584Phase 1
• Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung CancerCompletedNCT01510405
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1